ddrg/super_eurlex huggingface dataset:
Official Journal of the European Union

Authorisation for State aid pursuant to Articles 107 and 108 of the Treaty on the Functioning of the European Union

Cases where the Commission raises no objections

(2022/C 235/02)

Date of adoption of the decision 12.5.2022 Aid number SA.101092 Member State Denmark Region Denmark Title (title and/or name of the beneficiary) Compensation to vessel owners for the loss of income in the first quarter of 2021 due to Brexit (Danish title: Kompensation til ejere af fiskefartøjer for indkomststab i første kvartal af 2021 som følge af brexit) Legal basis Bekendtgørelse om kompensation til ejere af fiskefartøjer for indkomststab i første kvartal af 2021, som følge af brexit (Order on compensation to owners of fishing vessels for loss of income in the first quarter of 2021 due to Brexit) Type of measure Scheme Objective Fisheries and aquaculture, Other measures (Fisheries Guidelines point 5.7) Form of aid Direct grant Budget Overall budget: 25 000 000 DKK Annual budget: 25 000 000 DKK Intensity 100,0 % Duration Until 31.12.2023 Economic sectors Marine fishing Name and address of the granting authority Danish Fisheries Agency Nyropsgade 30, 1780 Copenhagen Other information

The authentic text(s) of the decision, from which all confidential information has been removed, can be found at:

https://ec.europa.eu/competition/elojade/isef/index.cfm

Date of adoption of the decision 10.5.2022 Aid number SA.102249 Member State Ireland Region Title (title and/or name of the beneficiary) Brexit Processing Capital Support Scheme Legal basis Brexit Processing Capital Support Scheme Type of measure Scheme Objective Fisheries and aquaculture, Aid for categories of measures covered by block exemption (FIBER, GBER) Form of aid Direct grant Budget Overall budget: 45 000 000 EUR Annual budget: 45 000 000 EUR Intensity 50,0 % Duration Until 31.12.2023 Economic sectors Processing and preserving of fish, crustaceans and molluscs Name and address of the granting authority Bord Iascaigh Mhara Crofton Road, Dunlaoghaire, County Dublin, Ireland Other information

The authentic text(s) of the decision, from which all confidential information has been removed, can be found at:

https://ec.europa.eu/competition/elojade/isef/index.cfm
Update of reference amounts for the crossing of the external borders, as referred to in Article 6(4) of Regulation (EU) 2016/399 of the European Parliament and of the Council on a Union Code on the rules governing the movement of persons across borders (Schengen Borders Code) (1)

(2022/C 258/08)

The publication of reference amounts for the crossing of the external borders, as referred to in Article 6(4) of Regulation (EU) 2016/399 of the European Parliament and of the Council of 9 March 2016 on a Union Code on the rules governing the movement of persons across borders (Schengen Borders Code) (2), is based on the information communicated by the Member States to the Commission in conformity with Article 39 of the Schengen Borders Code.

In addition to the publication in the Official Journal, a monthly update is available on the website of the Directorate-General for Migration and Home Affairs.

REFERENCE AMOUNTS REQUIRED FOR THE CROSSING OF THE EXTERNAL BORDER FIXED BY NATIONAL AUTHORITIES

ICELAND

Replacement of the information published in OJ C 247, 13.10.2006, p. 19.

Under Icelandic law, aliens must prove that they have enough money to meet their needs in Iceland and to make the return journey. In practice, the reference amount is set at ISK 8 000 per person per day. If the expenses connected with the stay are borne by a third party, the amount is halved. The total minimum amount is ISK 40 000 for each entry.

List of previous publications

OJ C 247, 13.10.2006, p. 19.

OJ C 77, 5.4.2007, p. 11.

OJ C 153, 6.7.2007, p. 22.

OJ C 164, 18.7.2007, p. 45.

OJ C 182, 4.8. 2007, p. 18.

OJ C 57, 1.3.2008, p. 38.

OJ C 134, 31.5.2008, p. 19.

OJ C 331, 31.12.2008, p. 13.

OJ C 33, 10.2. 2009, p. 1.

OJ C 36, 13.2. 2009, p. 100.

OJ C 37, 14.2.2009, p. 8.

OJ C 98, 29.4.2009, p. 11.

OJ C 35, 12.2.2010, p. 7.

OJ C 304, 10.11.2010, p. 5.

OJ C 24, 26.1.2011, p. 6.

OJ C 157, 27.5.2011, p. 8.

OJ C 203, 9.7.2011, p. 16.

OJ C 11, 13.1.2012, p. 13.

OJ C 72, 10.3.2012, p. 44.

OJ C 199, 7.7.2012, p. 8.

OJ C 298, 04.10.2012, p. 3.

OJ C 56, 26.2.2013, p. 13.

OJ C 98, 05.04.2013, p. 3.

OJ C 269, 18.09.2013, p. 2.

OJ C 57, 28.2.2014, p. 2.

OJ C 152, 20.5.2014, p. 25.

OJ C 224, 15.7.2014, p. 31.

OJ C 434, 4.12.2014, p. 3.

OJ C 447, 13.12.2014, p. 32.

OJ C 38, 4.2.2015, p. 20.

OJ C 96, 11.3.2016, p. 7.

OJ C 146, 26.4.2016, p.12.

OJ C 248, 8.7.2016, p. 12.

OJ C 111, 8.4.2017, p. 11.

OJ C 21, 20.1.2018, p. 3.

OJ C 93, 12.3.2018, p. 4.

OJ C 153, 2.5.2018, p. 8.

OJ C 186, 31.5.2018, p. 10.

OJ C 264, 26.07.2018, p. 6.

OJ C 366, 10.10.2018, p. 12.

OJ C 459, 20.12.2018, p. 38.

OJ C 140, 16.4. 2019, p. 7.

OJ C 178, 28.5. 2020, p. 3.

OJ C 102, 24.3. 2021, p. 8.

OJ C 486, 3.12. 2021, p. 26.

OJ C 139, 29.3. 2022, p. 3.

OJ C 143, 31.3. 2022, p. 6.

(1) See the list of previous publications at the end of this update.

(2) OJ L 77, 23.3.2016, p. 1.
Official Journal of the European Union

Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 May 2022 to 31 May 2022

(Decisions taken pursuant to Article 34 of Directive 2001/83/EC (1) , Article 38 of Directive 2001/82/EC (2) or Article 5 of Regulation (EU) 2019/6 of the European Parliament and of the Council (3) )

(2022/C 249/02)

— Suspension of a national marketing authorisation

Date of the decision Name(s) of the medicinal product INN (International Non-Proprietary Name) Holder(s) of the marketing authorisation Member State concerned Date of notification 24.5.2022 HES (hydroxyethyl starch) hydroxyethyl starch (HES), solutions for infusion See Annex See Annex 25.5.2022

(1) OJ L 311, 28.11.2001, p. 67.

(2) OJ L 311, 28.11.2001, p. 1.

(3) OJ L 4, 7.1.2019, p. 43.
Notice concerning a request pursuant to Article 35 of Directive 2014/25/EU

Request made by a Contracting Entity

(2022/C 343/05)

On 20 July 2022 the Commission received a request in accordance with Article 35 of Directive 2014/25/EU of the European Parliament and of the Council (1). The first working day following receipt of the request is 22 July 2022.

This request, submitted by the French authorities on behalf of Dalkia S.A., concerns the delegated management of district heating networks in France. Article 34 of Directive 2014/25/EU provides that ‘contracts intended to enable an activity mentioned in Articles 8 to 14 to be carried out shall not be subject to this Directive if the Member State or the contracting entities having introduced the request pursuant to Article 35 can demonstrate that, in the Member State in which it is performed, the activity is directly exposed to competition on markets to which access is not restricted; nor shall design contests that are organised for the pursuit of such an activity in that geographic area be subject to this Directive’. The assessment of direct exposure to competition that can be carried out in the context of Directive 2014/25/EU is without prejudice to the full-fledged application of competition law.

The Commission is allowed a period of 130 working days to take a decision on this request, commencing on the working day referred to above. This period therefore expires on 1 February 2023.

According to Article 35(5) of Directive 2014/25/EU, further requests concerning the same sector or activity in France before the expiry of the period opened in respect of this request shall not be considered as new procedures and shall be treated in the context of this request.

(1) Directive 2014/25/EU of the European Parliament and of the Council of 26 February 2014 on procurement by entities operating in the water, energy, transport and postal services sectors and repealing Directive 2004/17/EC (OJ L 94, 28.3.2014, p. 243).
Official Journal of the European Union

Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 July 2022 to 31 July 2022

(Decisions taken pursuant to Article 34 of Directive 2001/83/EC (1), Article 38 of Directive 2001/82/EC (2) or Article 5 of Regulation (EU) 2019/6 (3) of the European Parliament and of the Council)

(2022/C 331/02)

— Issuing, maintenance or modification of a national marketing authorisation

Date of the decision Name(s) of the medicinal product INN (International Non-Proprietary Name) Holder(s) of the marketing authorisation Member State concerned Date of notification 18.7.2022 Daruph and Anafezyn and associated names dasatinib (anhydrous) See Annex See Annex 19.7.2022

(1) OJ L 311, 28.11.2001, p. 67.

(2) OJ L 311, 28.11.2001, p. 1.

(3) OJ L 4, 7.1.2019, p. 43.
Official Journal of the European Union

Commission information notice pursuant to Article 17(5) of Regulation (EC) No 1008/2008 of the European Parliament and of the Council on common rules for the operation of air services in the Community

Invitation to tender in respect of the operation of scheduled air services in accordance with public service obligations

(Text with EEA relevance)

(2022/C 410/04)
Official Journal of the European Union

Authorisation for State aid pursuant to Articles 107 and 108 of the Treaty on the Functioning of the European Union

Cases where the Commission raises no objections

(2022/C 416/02)

Date of adoption of the decision 12.9.2022 Aid number SA.103301 Member State Germany Region Title (title and/or name of the beneficiary) Bund: Nationale Rahmenrichtlinie zur Gewährung staatlicher Zuwendungen zur Bewältigung von Schäden in der Land- und Forstwirtschaft verursacht durch Naturkatastrophen oder widrige Witterungsverhältnisse (zur Verlängerung und Änderung von SA.40354) Legal basis Nationale Rahmenrichtlinie zur Gewährung staatlicher Finanzhilfen zur Bewältigung von Schäden in der Land- und Forstwirtschaft verursacht durch Naturkatastrophen oder widrige Witterungsverhältnisse Type of measure Scheme Objective Compensation of damage caused by natural disasters or exceptional occurrences, Agriculture; Forestry; Rural areas Form of aid Direct grant, Interest subsidy, Soft loan Budget Overall budget: 4 500 000 000 EUR Annual budget: 750 000 000 EUR Intensity 100,0 % Duration Until 31.12.2028 Economic sectors AGRICULTURE, FORESTRY AND FISHING Name and address of the granting authority Bundesländer n/a Other information

The authentic text(s) of the decision, from which all confidential information has been removed, can be found at:

https://ec.europa.eu/competition/elojade/isef/index.cfm
Official Journal of the European Union

Summary of European Union decisions on marketing authorisations in respect of medicinal products of 10 November 2022

(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council (1) or Article 5 of Regulation (EU) 2019/6 of the European Parliament and of the Council (2))

(2022/C 429 I/01)

— Issuing of a marketing authorisation (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted Date of the decision Name of the medicinal product INN (International Non-Proprietary Name) Holder of the marketing authorisation Number of the entry in the Community Register Pharmaceutical form ATC code (Anatomical Therapeutic Chemical Code) Date of notification 10.11.2022 VidPrevtyn Beta COVID-19 vaccine (recombinant, adjuvanted) Sanofi Pasteur 14 Espace Henry Vallée, 69007 Lyon, France EU/1/21/1580 Solution and emulsion for emulsion for injection J07BX03 10.11.2022

Anyone wishing to consult the public assessment report on the medicinal products in question and the decisions relating thereto is invited to contact:

European Medicines Agency Domenico Scarlattilaan 6 1083 HS Amsterdam NETHERLANDS

(1) OJ L 136, 30.4.2004, p. 1.

(2) OJ L 4, 7.1.2019, p. 43.
Information communicated by Member States regarding closure of fisheries

(2022/C 421/05)

In accordance with Article 35(3) of Council Regulation (EC) No 1224/2009 of 20 November 2009 establishing a Union control system for ensuring compliance with the rules of the common fisheries policy (1), a decision has been taken to close the fishery as set down in the following table:

Date and time of closure 28.9.2022 Duration 28.9.2022 — 31.12.2022 Member State Italy Stock or Group of stocks ARS/GF8-11 Species Giant red shrimp (Aristaeomorpha foliacea) Zone GSA 8-9-10-11 Type(s) of fishing vessels — Reference number 09/TQ110

(1) OJ L 343, 22.12.2009, p. 1.
Commission notice on current State aid recovery interest rates and reference/discount rates applicable as from 1 December 2022

(Published in accordance with Article 10 of Commission Regulation (EC) No 794/2004 (1))

(2022/C 448/03)

Base rates calculated in accordance with the Communication from the Commission on the revision of the method for setting the reference and discount rates (OJ C 14, 19.1.2008, p. 6.). Depending on the use of the reference rate, the appropriate margins have still to be added as defined in this communication. For the discount rate this means that a margin of 100 basispoints has to be added. The Commission Regulation (EC) No 271/2008 of 30 January 2008 amending Regulation (EC) No 794/2004 foresees that, unless otherwise provided for in a specific decision, the recovery rate will also be calculated by adding 100 basispoints to the base rate.

Modified rates are indicated in bold.

Previous table published in OJ C 390, 11.10.2022, p. 3.

From To AT BE BG CY CZ DE DK EE EL ES FI FR HR HU IE IT LT LU LV MT NL PL PT RO SE SI SK UK 1.12.2022 31.12.2022 2,04 2,04 0,00 2,04 6,95 2,04 2,45 2,04 2,04 2,04 2,04 2,04 0,26 13,13 2,04 2,04 2,04 2,04 2,04 2,04 2,04 7,17 2,04 7,97 2,17 2,04 2,04 2,35 1.11.2022 30.11.2022 1,49 1,49 0,00 1,49 6,95 1,49 1,90 1,49 1,49 1,49 1,49 1,49 0,26 13,13 1,49 1,49 1,49 1,49 1,49 1,49 1,49 7,17 1,49 7,97 1,88 1,49 1,49 1,76 1.10.2022 31.10.2022 1,03 1,03 0,00 1,03 6,95 1,03 1,45 1,03 1,03 1,03 1,03 1,03 0,26 11,15 1,03 1,03 1,03 1,03 1,03 1,03 1,03 7,17 1,03 6,58 1,55 1,03 1,03 1,76 1.9.2022 30.9.2022 0,71 0,71 0,00 0,71 6,95 0,71 1,12 0,71 0,71 0,71 0,71 0,71 0,26 9,23 0,71 0,71 0,71 0,71 0,71 0,71 0,71 7,17 0,71 6,58 1,22 0,71 0,71 1,52 1.8.2022 31.8.2022 0,38 0,38 0,00 0,38 5,73 0,38 0,81 0,38 0,38 0,38 0,38 0,38 0,26 7,67 0,38 0,38 0,38 0,38 0,38 0,38 0,38 5,81 0,38 5,10 0,82 0,38 0,38 1,19 1.7.2022 31.7.2022 0,02 0,02 0,00 0,02 5,73 0,02 0,44 0,02 0,02 0,02 0,02 0,02 0,26 6,24 0,02 0,02 0,02 0,02 0,02 0,02 0,02 5,81 0,02 5,10 0,50 0,02 0,02 1,19 1.6.2022 30.6.2022 -0,19 -0,19 0,00 -0,19 4,85 -0,19 0,24 -0,19 -0,19 -0,19 -0,19 -0,19 0,26 6,24 -0,19 -0,19 -0,19 -0,19 -0,19 -0,19 -0,19 4,88 -0,19 4,40 0,22 -0,19 -0,19 1,02 1.5.2022 31.5.2022 -0,35 -0,35 0,00 -0,35 4,85 -0,35 0,08 -0,35 -0,35 -0,35 -0,35 -0,35 0,26 5,40 -0,35 -0,35 -0,35 -0,35 -0,35 -0,35 -0,35 4,06 -0,35 3,38 0,08 -0,35 -0,35 0,86 1.4.2022 30.4.2022 -0,49 -0,49 0,00 -0,49 4,00 -0,49 0,00 -0,49 -0,49 -0,49 -0,49 -0,49 0,26 4,66 -0,49 -0,49 -0,49 -0,49 -0,49 -0,49 -0,49 3,42 -0,49 3,38 -0,01 -0,49 -0,49 0,66 1.3.2022 31.3.2022 -0,49 -0,49 0,00 -0,49 4,00 -0,49 -0,03 -0,49 -0,49 -0,49 -0,49 -0,49 0,26 4,02 -0,49 -0,49 -0,49 -0,49 -0,49 -0,49 -0,49 2,85 -0,49 2,74 -0,04 -0,49 -0,49 0,66 1.2.2022 28.2.2022 -0,49 -0,49 0,00 -0,49 3,29 -0,49 -0,03 -0,49 -0,49 -0,49 -0,49 -0,49 0,26 3,17 -0,49 -0,49 -0,49 -0,49 -0,49 -0,49 -0,49 2,04 -0,49 2,74 -0,05 -0,49 -0,49 0,66 1.1.2022 31.1.2022 -0,49 -0,49 0,00 -0,49 2,49 -0,49 -0,01 -0,49 -0,49 -0,49 -0,49 -0,49 0,26 2,38 -0,49 -0,49 -0,49 -0,49 -0,49 -0,49 -0,49 1,21 -0,49 2,27 -0,03 -0,49 -0,49 0,51

(1) OJ L 140, 30.4.2004, p. 1.
Official Journal of the European Union

Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 October 2022 to 31 October 2022

(Decisions taken pursuant to Article 34 of Directive 2001/83/EC (1), Article 38 of Directive 2001/82/EC (2) or Article 5 of Regulation (EU) 2019/6 of the European Parliament and of the Council (3))

(2022/C 457/02)

— Issuing, maintenance or modification of a national marketing authorisation

Date of the decision Name(s) of the medicinal product INN (International Non-Proprietary Name) Holder(s) of the marketing authorisation Member State concerned Date of notification 28.10.2022 Nomegestrol and Chlormadinone nomegestrol or chlormadinone See Annex See Annex 31.10.2022

(1) OJ L 311, 28.11.2001, p. 67.

(2) OJ L 311, 28.11.2001, p. 1.

(3) OJ L 4, 7.1.2019, p. 43.
Commission information notice pursuant to Article 16(4) of Regulation 1008/2008 of the European Parliament and of the Council on common rules for the operation of air services in the Community

Public service obligations in respect of scheduled air services

(Text with EEA relevance)

(2022/C 485/05)

Member State Spain Route concerned Menorca-Madrid Reopening date of the PSO route to community air carriers 1 May 2023 Address where the text and any other information or documentation related to the public service obligations can be obtained. Ministerio de Transportes, Movilidad y Agenda Urbana Dirección General de Aviación Civil Subdirección General de Transporte Aéreo Paseo de la Castellana 67 28071 Madrid España Tel. +34 91 597 7837 Fax +34 91 597 8643 e-mail address: osp.dgac@mitma.es

The routes subject to public service obligations may be operated on the basis of free competition access as from 1 May 2023. In the event that no air carrier submits a program of services compliant with the public service obligations imposed, access will be restricted from 1 November 2023 to 30 April 2024 to a single air carrier through the corresponding public tender procedure, in accordance with Article 16 (9) of Regulation (EC) No 1008/2008.
Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)

(Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (1))

(Text with EEA relevance)

(2023/C 12/04)

Decision granting an authorisation

Reference of the decision (2) Date of decision Substance name Holder(s) of the authorisation Authorisation number Authorised use Date of expiry of review period Reasons for the decision C(2023) 31 6 January 2023 4-(1,1,3,3-Tetra methylbutyl)phenol, ethoxylated (4-tert-OPnEO) EC No: -, CAS No:- AGC Biologics A/S, Vandtårnsvej 83 B, 2860, Søborg, Denmark AGC Biologics GmbH, Czernyring 22, 69115, Heidelberg, Germany REACH/22/45/0 REACH/22/45/1 REACH/22/45/2 REACH/22/45/3 As a detergent for the inactivation of viruses in the production of therapeutic proteins using mammalian cell hosts As a detergent during the purification process of recombinant biopharmaceuticals derived from microbial expression hosts I projects where processes have been approved by authorities (where processes are Good Manufacturing Practice compliant) 4 January 2033 In accordance with Article 60(4) of Regulation (EC) No 1907/2006, the socio-economic benefits outweigh the risk to human health and the environment from the uses of the substance and there are no suitable alternative substances or technologies.

(1) OJ L 396, 30.12.2006 , p. 1.

(2) The decision is available on the European Commission website at: Authorisation (europa.eu).
Notice concerning the application of the Registered Exporter system of the European Union by Côte d’Ivoire and Madagascar under, respectively, the EU - Côte d’Ivoire stepping-stone Economic Partnership Agreement and the EU – Eastern and Southern Africa interim EPA

(2023/C 23/04)

This notice is issued for the information of customs authorities, importers and economic operators, which are involved in imports into the European Union of products originating in:

— Côte d’Ivoire under the EU-Côte d’Ivoire stepping-stone Economic Partnership Agreement (‘the stepping-stone EPA’); and

— Madagascar under the EU-Eastern and Southern Africa interim Economic Partnership Agreement (‘the EU-ESA iEPA’).

Complementing the notice 2022/C 452/06 of 29 November 2022, Côte d’Ivoire has notified the European Commission that, in accordance with its Circular No 2226/MBPE/DGD of 16 November 2022, exporters from Côte d’Ivoire are registered in the Registered Exporter system of the European Union (‘the REX system’). Therefore, as from 2 December 2022, products originating in Côte d’Ivoire shall, on importation into the EU, benefit from the preferential tariff treatment of the stepping-stone EPA only upon submission of an origin declaration made out, as provided for in Article 21 of Protocol No 1, by:

(i) an exporter from Côte d’Ivoire registered in the REX system, or

(ii) any exporter from Côte d’Ivoire, for any consignment consisting of one or more packages containing originating products, the total value of which does not exceed EUR 6 000.

Following a notification made by Madagascar to the Customs Cooperation Committee of the EU-ESA iEPA activating Article 18(3) of Protocol 1 to the EU-ESA iEPA (1), and without prejudice to the exemptions laid down in Articles 18(2) and 29 of Protocol 1, as from 1 January 2023, products originating in Madagascar shall, on importation into the EU, benefit from the preferential tariff treatment of the EU-ESA iEPA only upon submission of an invoice declaration made out, as provided for in Article 23 of Protocol 1, by:

(i) an exporter from Madagascar registered in the REX system, or

(ii) any exporter from Madagascar, for any consignment consisting of one or more packages containing originating products, the total value of which does not exceed EUR 6 000.

From that date, paragraphs 1(a) and (b) of Article 18 shall cease to apply for imports into the EU of originating products in Madagascar.

(1) As amended by Decision 1/2020 of 14 January 2020 of the EU-ESA EPA Committee
51994AP0275

RESOLUTION embodying the opinion of the European Parliament in accordance with the procedure without report (Rule 143) on the proposal for a Council Regulation amending Regulation (EEC) N. 3438/92 laying down special measures for the transport of certain fresh fruit and vegetables originating in Greece as regards the duration of their application (COM(94)0534 - C4-0275/94 - 94/0273(CNS)) (Consultation procedure)



Official Journal C 056 , 06/03/1995 P. 0164
Proposal for a Council Regulation fixing the aid in respect of silkworms for the 1995/96 rearing year (COM(95)0034 - C4-0064/95 - 95/0043(CNS))

The proposal was approved.

Legislative resolution embodying Parliament's opinion on the proposal for a Council Regulation fixing the aid in respect of silkworms for the 1995/96 rearing year (COM(95)0034 - C4-0064/95 - 95/0043(CNS))

(Consultation procedure)

The European Parliament,

- having regard to the Commission proposal to the Council, COM(95)0034 - 95/0043(CNS) ((OJ C 99, 21.4.1995, p. 18.)),

- having been consulted by the Council (C4-0064/95),

- having regard to Rule 58 of its Rules of Procedure,

- having regard to the report of the Committee on Agriculture and Rural Development and the opinions of the Committee on Budgets, the Committee on External Economic Relations, the Committee on the Environment, Public Health and Consumer Protection and the Committee on Development and Cooperation (A4-0100/95),

1. Approves the Commission proposal;

2. Calls on the Council to notify Parliament should it intend to depart from the text approved by Parliament;

3. Asks to be consulted again should the Council intend to make substantial modifications to the Commission proposal;

4. Instructs its President to forward this opinion to the Council and Commission.